Publication | Open Access
<scp>NVP</scp>‐<scp>QBE</scp>170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia
21
Citations
40
References
2015
Year
NVP-QBE170 highlights the potential for inhaled ENaC blockers to exhibit efficacy in the airways with a reduced risk of hyperkalaemia, relative to existing compounds.
| Year | Citations | |
|---|---|---|
Page 1
Page 1